Melatonin improves non-alcoholic fatty liver disease via MAPK-JNK/P38 signaling in high-fat-diet-induced obese mice

BACKGROUND: Melatonin can regulate lipid metabolism, increase insulin sensitivity, regulate glucose metabolism and reduce body weight. This study is aimed to determine the effects and mechanism of action of melatonin on non-alcoholic fatty liver disease (NAFLD) in high-fat-diet (HFD) induced obese m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Lipids Health Dis
Autors principals: Sun, Hang, Wang, Xingchun, Chen, Jiaqi, Song, Kexiu, Gusdon, Aaron M., Li, Liang, Bu, Le, Qu, Shen
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5120511/
https://ncbi.nlm.nih.gov/pubmed/27876064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-016-0370-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars